2024. Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy. Journal of Carcinogenesis. 23, 1 (Dec. 2024), 860–870. DOI:https://doi.org/10.64149/J.Carcinog.24.6s.232-242.